Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion type Assertion NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_head.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion description "[RAR-beta2 expression was studied by reverse transcription-polymerase chain reaction (RT-PCR) analysis in eight breast cancer cell lines that were either treated with the demethylating agent 5-aza-2'-deoxycytidine and subsequently with all-trans-retinoic acid (ATRA) or left untreated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion evidence source_evidence_literature NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion SIO_000772 10814678 NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion wasDerivedFrom befree-20150227 NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.
- NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_assertion wasGeneratedBy ECO_0000203 NP856787.RAkr19YjpkzLdO0TmlZWKXKGQ3rP1y3QUVUz0ogpBck_8130_provenance.